| ²é¿´: 654 | »Ø¸´: 1 | ||
| ¡¾ÐüÉͽð±Ò¡¿»Ø´ð±¾ÌûÎÊÌ⣬×÷ÕßµãµãÓðÂ佫ÔùËÍÄú 50 ¸ö½ð±Ò | ||
µãµãÓðÂä½ð³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
¼±ÇóSASͳ¼Æ´óÉñ
|
|
|
SCIÎÄÕ¶þÉó£¬ÓÐûÓÐͳ¼Æ´óÉñ°¡£¬¶þÉóÆäÖÐÎÊÌ⣺ÔÚ2.5 Statistical analysis£ºÐè˵Ã÷SASͳ¼ÆÄ£Ê½°üÀ¨ÄÄЩÏîÄ¿£¿ÒÔ¼°·½²î·ÖÎöÓ°ÏìÏÔÖøÊ±£¬ÓÃɶ·½·¨½øÐи÷´¦ÀíÆ½¾ùÊý¼äµÄ²îÒìÏÔÖøÐÔ¼ìÑ飿 ֮ǰÎÒдµÄ 2.5 Statistical analysis The treatment effects were assessed by the GLM procedure of ANOVA (version 9.4, SAS inst, Inc., Cary, NC), where pen was the statistical unit. The linear and quadratic effects of saccharicterpenin level were assessed using orthogonal polynomials. P < 0.05 was used as the criterion for statistical significance. ÎÒÐèÒªÔõôÐ޸ĸ÷λ´óÉñ°ï°ïæ¡£ |
» ²ÂÄãϲ»¶
ÓжàÉÙÈËÊǽñÌì²éϵͳ֪µÀ½á¹ûµÄ£¿
ÒѾÓÐ8È˻ظ´
¹ú¼ÊºÏ×÷¿É²éÁË£¬ÖÐÁËÃæÉÏ
ÒѾÓÐ17È˻ظ´
Ôõô²é°¡
ÒѾÓÐ3È˻ظ´
¹úºÏ¿É²éÁË
ÒѾÓÐ3È˻ظ´
ϵͳ½ø²»È¥
ÒѾÓÐ4È˻ظ´
ϵͳ²é²»µ½
ÒѾÓÐ3È˻ظ´
Ôõô¿´Çà»ùÖÐÁËûÓа¡
ÒѾÓÐ3È˻ظ´
¹úºÏÀïÃæÄÜ¿´µ½ÁË
ÒѾÓÐ6È˻ظ´
½ñÌìÎñί»á¿ªÍêÁË£¬Ã÷Ìì³ö½á¹ûÂð
ÒѾÓÐ23È˻ظ´
¿ÆÑй¶ùÌ«ÄÑÁË
ÒѾÓÐ20È˻ظ´

µãµãÓðÂä
½ð³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1044.9
- É¢½ð: 76
- ºì»¨: 4
- ɳ·¢: 1
- Ìû×Ó: 706
- ÔÚÏß: 84.8Сʱ
- ³æºÅ: 7115343
- ×¢²á: 2017-08-29
- רҵ: ÐóÄÁѧ

2Â¥2019-04-04 15:17:33









»Ø¸´´ËÂ¥
ͶƱ: